Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maurizio Ricci

Showing results (1-10 of 133) with videos related to

Pageof 14
Sort By:
Drug Development and Industrial Pharmacy|December 16, 2016
The long and winding road to inhaled TB therapy: not only the bug's faultStefano Giovagnoli, Aurelie Schoubben, Maurizio Ricci
AAPS Pharmscitech|January 4, 2019
Exploring the Nano Spray-Drying Technology as an Innovative Manufacturing Method for Solid Lipid Nanoparticle Dry PowdersKrystyna Glaubitt, Maurizio Ricci, Stefano Giovagnoli
International Journal of Pharmaceutics|December 28, 2022
Development of spray-dried N-acetylcysteine dry powder for inhalationLorenzo Mancini, Marco Paolantoni, Aurélie Schoubben, et al.
Current Medicinal Chemistry|June 22, 2006
Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?Maurizio Ricci, Paolo Blasi, Stefano Giovagnoli, et al.
Pharmaceutics|April 30, 2021
Tackling Immune Pathogenesis of COVID-19 through Molecular PharmaceuticsMatteo Puccetti, Claudio Costantini, Maurizio Ricci, et al.
AAPS Pharmscitech|March 12, 2005
Biodegradable microspheres as carriers for native superoxide dismutase and catalase deliveryStefano Giovagnoli, Paolo Blasi, Maurizio Ricci, et al.
International Journal of Molecular Sciences|February 11, 2023
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?Matteo Puccetti, Aurelie Schoubben, Stefano Giovagnoli, et al.
Pharmaceutics|July 9, 2020
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?Matteo Puccetti, Styliani Xiroudaki, Maurizio Ricci, et al.
Recenti Progressi in Medicina|March 12, 2020
[Dermo-cosmetic control of cutaneous adverse effects in the oncological patient.]Maria Cristina Tiralti, Luana Perioli, Cinzia Pagano, et al.
Frontiers in Immunology|October 10, 2022
Editorial: From microbial immunology to microbial therapeutics <i>via</i> targeted delivery technologyMatteo Puccetti, César Viseras Iborra, Luigina Romani, et al.
Pageof 14

Showing results (1-10 of 133) with videos related to

Sort By:
Pageof 14
Drug Development and Industrial Pharmacy|December 16, 2016
The long and winding road to inhaled TB therapy: not only the bug's faultStefano Giovagnoli, Aurelie Schoubben, Maurizio Ricci
AAPS Pharmscitech|January 4, 2019
Exploring the Nano Spray-Drying Technology as an Innovative Manufacturing Method for Solid Lipid Nanoparticle Dry PowdersKrystyna Glaubitt, Maurizio Ricci, Stefano Giovagnoli
International Journal of Pharmaceutics|December 28, 2022
Development of spray-dried N-acetylcysteine dry powder for inhalationLorenzo Mancini, Marco Paolantoni, Aurélie Schoubben, et al.
Current Medicinal Chemistry|June 22, 2006
Delivering drugs to the central nervous system: a medicinal chemistry or a pharmaceutical technology issue?Maurizio Ricci, Paolo Blasi, Stefano Giovagnoli, et al.
Pharmaceutics|April 30, 2021
Tackling Immune Pathogenesis of COVID-19 through Molecular PharmaceuticsMatteo Puccetti, Claudio Costantini, Maurizio Ricci, et al.
AAPS Pharmscitech|March 12, 2005
Biodegradable microspheres as carriers for native superoxide dismutase and catalase deliveryStefano Giovagnoli, Paolo Blasi, Maurizio Ricci, et al.
International Journal of Molecular Sciences|February 11, 2023
Biodrug Delivery Systems: Do mRNA Lipid Nanoparticles Come of Age?Matteo Puccetti, Aurelie Schoubben, Stefano Giovagnoli, et al.
Pharmaceutics|July 9, 2020
Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline?Matteo Puccetti, Styliani Xiroudaki, Maurizio Ricci, et al.
Recenti Progressi in Medicina|March 12, 2020
[Dermo-cosmetic control of cutaneous adverse effects in the oncological patient.]Maria Cristina Tiralti, Luana Perioli, Cinzia Pagano, et al.
Frontiers in Immunology|October 10, 2022
Editorial: From microbial immunology to microbial therapeutics <i>via</i> targeted delivery technologyMatteo Puccetti, César Viseras Iborra, Luigina Romani, et al.
Pageof 14